These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12802842)

  • 21. Nicotinic acid in the treatment of hyperlipidaemia.
    Drexel H
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():5-6. PubMed ID: 18001312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemia.
    Kastelein JJ; Sankatsing RR
    Int J Clin Pract; 2005 Dec; 59(12):1464-71. PubMed ID: 16351680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New drug against lipid disorders. HDL level rises 30%].
    MMW Fortschr Med; 2003 Sep; 145(39):51. PubMed ID: 14649076
    [No Abstract]   [Full Text] [Related]  

  • 24. Drugs for lipids.
    Treat Guidel Med Lett; 2005 Mar; 3(31):15-22. PubMed ID: 15726011
    [No Abstract]   [Full Text] [Related]  

  • 25. Extended-release niacin/lovastatin: the first combination product for dyslipidemia.
    Bays HE
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):485-501. PubMed ID: 15225109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hyperlipidemia: therapeutic principles in clinical practice].
    Müller-Wieland D; Krone W
    Med Klin (Munich); 2003 Dec; 98(12):739-43. PubMed ID: 14685674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of hyperlipidemia with a new drug, tibric acid].
    Carmena R; González R Florez J; Sanchis J
    Rev Clin Esp; 1976 Jul; 142(2):151-5. PubMed ID: 788065
    [No Abstract]   [Full Text] [Related]  

  • 28. [Goal in hypercholesterolemia: lowering LDL cholesterol level by 50%].
    MMW Fortschr Med; 2005 Jul; 147(27-28):51. PubMed ID: 16041948
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination therapy for the treatment of dyslipidemia.
    Streja D
    Curr Opin Investig Drugs; 2004 Mar; 5(3):306-12. PubMed ID: 15083597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins as the cornerstone of drug therapy for dyslipidemia: monotherapy and combination therapy options.
    Jones PH
    Am Heart J; 2004 Jul; 148(1 Suppl):S9-13. PubMed ID: 15211327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospects for the development of novel anti-hyperlipidemic drugs.
    Derosa G; Salvadeo S; Cicero AF
    Curr Opin Investig Drugs; 2006 Sep; 7(9):826-33. PubMed ID: 17002261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On call. I don't understand the problem with Vytorin. The two components when used separately work fine, but when mixed together things change. Why?
    Simon HB
    Harv Mens Health Watch; 2008 Oct; 13(3):8. PubMed ID: 19035013
    [No Abstract]   [Full Text] [Related]  

  • 33. [Role of hyperlipidemia and its treatment].
    Ouellet A
    Union Med Can; 1991; 120(3):238-43. PubMed ID: 1866844
    [No Abstract]   [Full Text] [Related]  

  • 34. [Changes in lysozyme activity in hyperlipidemia and atherosclerosis in animals].
    Postnikova NV; Vasilenko IuK; Cherevatyĭ VS
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (4):53-6. PubMed ID: 4005328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing niacin as an atherosclerosis therapeutic agent valuable insights provided by high-resolution vascular magnetic resonance imaging.
    Jaffer FA
    J Am Coll Cardiol; 2009 Nov; 54(19):1795-6. PubMed ID: 19874993
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antihyperlipidemic actions in the treatment of nephropathies].
    Neverov NI; Tareeva IE; Miroshnichenko NG; Stavrovskaia EV
    Ter Arkh; 1995; 67(8):15-7. PubMed ID: 7482321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dyslipidaemia in diabetes.
    Patel J
    Clin Evid; 2006 Jun; (15):555-75. PubMed ID: 16973026
    [No Abstract]   [Full Text] [Related]  

  • 38. Adherence and persistence with single-dosage form extended-release niacin/lovastatin compared with statins alone or in combination with extended-release niacin.
    LaFleur J; Thompson CJ; Joish VN; Charland SL; Oderda GM; Brixner DI
    Ann Pharmacother; 2006; 40(7-8):1274-9. PubMed ID: 16849622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The management of hyperlipoproteinemia with Liproreduct].
    Fenster R
    Ther Ggw; 1974 May; 113(5):813-24. PubMed ID: 4603893
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of patients with dyslipidaemia.
    Mann J; Chisholm A; Crooke M; Jackson R; Neutze J; North D; Swinburn B; White H; Wilcox J
    N Z Med J; 1995 Oct; 108(1010):444. PubMed ID: 7478355
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.